HPV (human papillomavirus) test better than second Pap if smear result ambiguous
This article was originally published in Clinica
Women with ambiguous cervical smear results may benefit from subsequent testing with a new DNA test for human papillomavirus (HPV) - the agent that causes almost all cervical cancer - rather than a second Pap smear, say researchers from one of the largest health maintenance organisations in the US.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.